The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Dudchenko N.G.

Russian Medical Academy of Continuous Professional Education

Gadzhieva Z.F.

Russian Medical Academy of Continuing Professional Education

Coloman I.I.

Russian Medical Academy of Continuous Professional Education

Kuzmina A.V.

A.I. Yevdokimov Moscow State University of Medicine and Dentistry

Levin O.S.

Russian Medical Academy of Continuous Professional Education

Respiratory dysfunction in Parkinson’s disease

Authors:

Dudchenko N.G., Gadzhieva Z.F., Coloman I.I., Kuzmina A.V., Levin O.S.

More about the authors

Read: 12753 times


To cite this article:

Dudchenko NG, Gadzhieva ZF, Coloman II, Kuzmina AV, Levin OS. Respiratory dysfunction in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(10‑2):80‑85. (In Russ.)
https://doi.org/10.17116/jnevro202112110280

Recommended articles:
Stress and sleep: Neurobiological aspe­cts and modern options of inso­mnia therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):14-21
Cognitive impairment in patients with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):67-73
Sleep diso­rders in patients with Lewy body deme­ntia and Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):81-87
Influence of griseofulvin on inte­stinal microbiota in the treatment of microsporia in rural children. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):185-190
Art and creativity in Parkinson’s disease: the mysterious effe­cts of dopa­mine. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):13-20
Correlation of motor symptoms and cardiovascular dysfunction in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):59-67
Early diagnosis and effe­ctive therapy of diabetic poly­neuropathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):62-68

References:

  1. Parkinson J. An essay on the shaking palsy. MacMillan Magazines. 1992. https://doi.org/10.1176/jnp.14.2.223
  2. Baille G, Chenivesse C, Perez T, Machuron F, Dujardin K, Devos D, Moreau C. Dyspnea: An underestimated symptom in Parkinson’s disease. Parkinsonism & Related Disorders. 2019;60:162-166.  https://doi.org/10.1016/j.parkreldis.2018.09.001
  3. Moreau C, Devos D, Baille G, Delval A, Tard C, Perez T, Defebvre L. Are upper-body axial symptoms a feature of early Parkinson’s disease? PloS one. 2016;11(9):e0162904. https://doi.org/10.1371/journal.pone.0162904
  4. Vijayan S, Singh B, Ghosh S, Stell R, Mastaglia FL. Brainstem ventilatory dysfunction: A plausible mechanism for dyspnea in Parkinson’s Disease? Movement Disorders. 2020;35(3):379-388.  https://doi.org/10.1002/mds.27932
  5. American Thoracic Society. Dyspnea: mechanisms, assessment, and management: a consensus statement. Am J Respir Crit Care Med. 1999;159:321-340.  https://doi.org/10.1164/ajrccm.159.1.ats898
  6. Shill H, Stacy M. Respiratory function in Parkinson’s disease. Clinical Neuroscience (New York, NY). 1998;5(2):131-135. 
  7. Fontana GA, Pantaleo T, Lavorini F, Benvenuti F, Gangemi S. Defective motor control of coughing in Parkinson’s disease. American Journal of Respiratory and Critical Care Medicine. 1998;158(2):458-464.  https://doi.org/10.1164/ajrccm.158.2.9705094
  8. Mulkey DK, Wenker IC, Kréneisz O. Current ideas on central chemoreception by neurons and glial cells in the retrotrapezoid nucleus. J Appl Physiol. 2010;108(5):1433-1439. https://doi.org/10.1152/japplphysiol.01240.2009
  9. Moreira TS, Takakura AC, Damasceno RS, et al. Central chemoreceptors and neural mechanisms of cardiorespiratory control. Braz J Med Biol Res. 2011;44(9):883-889.  https://doi.org/10.1590/s0100-879x2011007500094
  10. Vijayan S, Singh B, Ghosh S, Stell R, Mastaglia FL. Brainstem ventilatory dysfunction: A plausible mechanism for dyspnea in Parkinson’s Disease? Movement Disorders. 2020;35(3):379-388.  https://doi.org/10.1002/mds.27932
  11. Talbot NP, Smith TG, Dorrington KL. The mechanics and control of ventilation. Surgery (Oxford). 2011;29(5):212-216.  https://doi.org/10.1016/j.mpsur.2011.02.004
  12. Pilowsky PM, Lung MS, Spirovski D, McMullan S. Differential regulation of the central neural cardiorespiratory system by metabotropic neurotransmitters. Philosophical Transactions of the Royal Society B: Biological Sciences. 2009;364(1529):2537-2552. https://doi.org/10.1098/rstb.2009.0092
  13. Buchanan GF, Richerson GB. Role of chemoreceptors in mediating dyspnea. Respiratory Physiology & Neurobiology. 2009;167(1):9-19.  https://doi.org/10.1016/j.resp.2008.12.002
  14. Spyer KM, Gourine AV. Chemosensory pathways in the brainstem controlling cardiorespiratory activity. Philosophical Transactions of the Royal Society B: Biological Sciences. 2009;364(1529):2603-2610. https://doi.org/10.1098/rstb.2009.0082
  15. Burki NK, Lee LY. Mechanisms of dyspnea. Chest. 2010;138(5):1196-1201. https://doi.org/10.1378/chest.10-0534
  16. Lunberg D, Mueller RA, Breese GR. Effects of vagotomy and glossopharyngectomy on respiratory response to dopamine-agonists. Acta Physiol Scand. 1982;114:81-89.  https://doi.org/10.1111/j.1748-1716.1982.tb06955.x
  17. Oliveira LM, Baertsch NA, Moreira TS, Ramirez JM, Takakura AC. Unraveling the mechanisms underlying irregularities in inspiratory rhythm generation in a mouse model of Parkinson’s disease. Journal of Neuroscience. 2021;41(21):4732-4747. https://doi.org/10.1523/JNEUROSCI.2114-20.2021
  18. Lima JC, Oliveira LM, Botelho MT, et al. The involvement of thepathway connecting the substantia nigra, the periaqueductal gray matter and the retrotrapezoid nucleus in breathing control in a rat model of Parkinson’s disease. Exp Neurol. 2018;302:46-56.  https://doi.org/10.1016/j.expneurol.2018.01.003
  19. Onodera H, Okabe S, Kikuchi Y, Tsuda T, Itoyama Y. Impaired chemosensitivity and perception of dyspnoea in Parkinson’s disease. The Lancet. 2000;356(9231):739-740.  https://doi.org/10.1016/S0140-6736(00)02638-6
  20. Serebrovskaya T, Karaban I, Mankovskaya I, Bernardi L, Passino C, Appenzeller O. Hypoxic ventilatory responses and gas exchange in patients with Parkinson’s disease. Respiration. 1998;65(1):28-33.  https://doi.org/10.1159/000029224
  21. Seccombe LM, Giddings HL, Rogers PG, Corbett AJ, Hayes MW, Peters MJ, Veitch EM. Abnormal ventilatory control in Parkinson’s disease — Further evidence for non-motor dysfunction. Respiratory Physiology & Neurobiology. 2011;179(2-3):300-304.  https://doi.org/10.1016/j.resp.2011.09.012
  22. Yust-Katz S, Shitrit D, Melamed E, Djaldetti R. Respiratory distress: an unrecognized non-motor phenomenon in patients with parkinsonism. Journal of Neural Transmission. 2012;119(1):73-76.  https://doi.org/10.1007/s00702-011-0671-0
  23. Ebihara S, Saito H, Kanda A, Nakajoh M, Takahashi H, Arai H, Sasaki H. Impaired efficacy of cough in patients with Parkinson disease. Chest. 2003;3:1009-1015. https://doi.org/10.1378/chest.124.3.1009
  24. Vincken WG, Gauthier SG, Dollfuss RE, Hanson RE, Darauay CM, Cosio MG. Involvement of upper-airway muscles in extrapyramidal disorders: a cause of airflow limitation. New England Journal of Medicine. 1984;311(7):438-442.  https://doi.org/10.1056/NEJM198408163110704
  25. Pokusa M, Hajduchova D, Buday T, Kralova Trancikova A. Respiratory Function and Dysfunction in Parkinson-Type Neurodegeneration. Physiological Research. 2020;69:23-29.  https://doi.org/10.33549/physiolres.934405
  26. Izquierdo-Alonso JL, Jimenez-Jimenez FJ, Cabrera-Valdivia F, Mansilla-Lesmes M. Airway dysfunction in patients with Parkinson’s disease. Lung. 1994;172(1):47-55.  https://doi.org/10.1007/BF00186168
  27. Estenne M, Hubert M, De Troyer A. Respiratory-muscle involvement in Parkinson’s disease. The New England Journal of Medicine. 1984;311(23):1516-1517. https://doi.org/10.1056/NEJM198412063112314
  28. De Pandis MF, Starace A, Stefanelli F, Marruzzo P, Meoli I, De Simone G, Stocchi F. Modification of respiratory function parameters in patients with severe Parkinson’s disease. Neurological Sciences. 2002;23(2):69-70.  https://doi.org/10.1007/s100720200074
  29. Baille G, Perez T, Devos D, Deken V, Defebvre L, Moreau C. Early occurrence of inspiratory muscle weakness in Parkinson’s disease. PLoS One. 2018;13(1):e0190400. https://doi.org/10.1371/journal.pone.0190400
  30. Pal PK, Sathyaprabha TN, Tuhina P, Thennarasu K. Pattern of subclinical pulmonary dysfunctions in Parkinson’s disease and the effect of levodopa. Movement Disorders: Official Journal of the Movement Disorder Society. 2007;22(3):420-424.  https://doi.org/10.1002/mds.21330
  31. Docu Axelerad A, Stroe AZ, Arghir OC, Docu Axelerad D, Gogu AE. Respiratory Dysfunctions in Parkinson’s Disease Patients. Brain Sciences. 2021;11(5):595.  https://doi.org/10.3390/brainsci11050595
  32. Lihachev SA, Vashilin VV. Respiratory disorders in Parkinson’s disease. In Parkinson’s Disease and Movement Disorders. 2011;105-108. (In Russ.).
  33. Sabaté M, González I, Ruperez F, Rodríguez M. Obstructive and restrictive pulmonary dysfunctions in Parkinson’s disease. Journal of the Neurological Sciences. 1996;138(1-2):114-119.  https://doi.org/10.1016/0022-510x(96)00003-2
  34. Wang Y, Shao WB, Gao L, Lu J, Gu H, Sun LH, Zhang YD. Abnormal pulmonary function and respiratory muscle strength findings in Chinese patients with Parkinson’s disease and multiple system atrophy — comparison with normal elderly. PLoS One. 2014;9(12):e116123. https://doi.org/10.1371/journal.pone.0116123
  35. Torsney KM, Forsyth D. Respiratory dysfunction in Parkinson’s disease. 2017. https://doi.org/10.4997/JRCPE.2017.108
  36. Tambasco N, Murgia N, Nigro P, Paoletti FP, Romoli M, Brahimi E, Filidei M, Simoni S, Muzi G, Calabresi P. Levodopa-responsive breathing discomfort in Parkinson’s disease patients. J Neural Transm. 2018;125:1033-1036. https://doi.org/10.1007/s00702-018-1890-4
  37. Witjas T, Kaphan E, Azulay JP, Blin O, Ceccaldi M, Pouget J, Poncet M, Chérif AA. Nonmotor fluctuations in Parkinson’s disease: frequent and disabling. Neurology. 2002;59(3):408-413.  https://doi.org/10.1212/wnl.59.3.408
  38. Vercueil L, Linard JP, Wuyam B, et al. Breathing pattern in patients with Parkinson’s disease. Respir Physiol. 1999;118(2-3):163-172.  https://doi.org/10.1016/s0034-5687(99)00075-4
  39. Khan W, Naz S, Rana AQ. Shortness of breath, a ‘wearing-off’symptom in Parkinson’s disease. Clinical drug Investigation. 2009;29(10):689-691.  https://doi.org/10.2165/11315290-000000000-00000
  40. Nutt JG. Levodopa‐induced dyskinesia: review, observations, and speculations. Neurology. 1990;40(2):340-340.  https://doi.org/10.1212/wnl.40.2.340
  41. Rice JE, Antic R, Thompson PD. Disordered respiration as a levodopa-induced dyskinesia in Parkinson’s disease. Mov Disord. 2002;17(3):524-527.  https://doi.org/10.1002/mds.10072
  42. Weiner WJ, Goetz CG, Nausieda PA, Klawans HL. Respiratory dyskinesias: extrapyramidal dysfunction and dyspnoea. Ann Intern Med. 1978;88:327-331. 
  43. Jankovic J, Nour F. Respiratory dyskinesia in Parkinson’s disease. Neurology. 1986;36(2):303-303.  https://doi.org/10.1212/wnl.36.2.303-b
  44. Levin OS, Ivanov AK, Shyndryaeva NN. Treatment of non-motor fluctuations with combined drug stalevo in patients with Parkinson disease. AZh Nevrol Psikhiatr im. S.S. Korsakova. 2011;111:1:38-43. (In Russ.).

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.